Les nouveaux anticoagulants oraux : halte à la polémique !
dc.contributor.author | Smadja, David M. | |
dc.date.accessioned | 2020-01-23T09:11:58Z | |
dc.date.available | 2020-01-23T09:11:58Z | |
dc.date.issued | 2013-10 | |
dc.description | p.1044-1047 | en_US |
dc.identifier.issn | 0035-2640 | |
dc.identifier.uri | http://repository.usthb.dz//xmlui/handle/123456789/7988 | |
dc.language.iso | fr | en_US |
dc.relation.ispartofseries | In : Revue du Praticien, T63, n°8 (Oct. 2013); | |
dc.subject | Anticoagulants oraux directs | en_US |
dc.subject | NACO (pharmacie) | en_US |
dc.subject | Antivitamines K | en_US |
dc.subject | AVK | en_US |
dc.subject | Pradaxa (dabigatran) | en_US |
dc.subject | Xarelto (rivaroxaban) | en_US |
dc.subject | Eliquis (apixaban) | en_US |
dc.title | Les nouveaux anticoagulants oraux : halte à la polémique ! | en_US |
dc.type | Article | en_US |